| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 43.76M | — |
| Operating expense | — | — |
| Net income | -99.34M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ORGO returned -63.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -65.3% |
| 1 year | -63.2% |
| 5 years | -89.4% |
| All-time high | $22.36 (Apr 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ORGO would be worth today ›No. Organogenesis Holdings Inc. has not paid a dividend in the past 12 months.
Organogenesis Holdings Inc. stock trades on NASDAQ under the ticker symbol ORGO.
Organogenesis Holdings Inc. is part of the Healthcare sector.
Organogenesis Holdings Inc. has a market cap of 231.61M USD, based on the latest quote.
Organogenesis Holdings Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
